questionsmedicales.fr
Maladies de l'appareil respiratoire
Maladies pulmonaires
Bronchopneumopathies obstructives
Bronchiolite oblitérante
Bronchiolite oblitérante : Questions médicales fréquentes
Diagnostic
5
Bronchiolite oblitérante
Biopsie pulmonaire
Fonction pulmonaire
Spirométrie
Tomodensitométrie
Obstruction bronchique
Biopsie pulmonaire
Diagnostic différentiel
Symptômes
5
Variabilité des symptômes
Patient
Progression de la maladie
Symptômes
Asthme
Respiration sifflante
Prévention
5
Prévention
Irritants pulmonaires
Tabagisme
Maladies pulmonaires
Vaccination
Infections respiratoires
Greffe pulmonaire
Immunosuppresseurs
Pollution de l'air
Facteurs environnementaux
Traitements
5
Corticostéroïdes
Réhabilitation pulmonaire
Transplantation pulmonaire
Cas sévères
Qualité de vie
Fonction pulmonaire
Thérapies biologiques
Traitements expérimentaux
Complications
5
Insuffisance respiratoire
Fibrose pulmonaire
Insuffisance respiratoire
Complications
Infections pulmonaires
Obstruction bronchique
Fibrose pulmonaire
Irréversibilité
Espérance de vie
Complications graves
Facteurs de risque
5
Facteurs de risque
Irritants
Antécédents médicaux
Maladies auto-immunes
Exposition professionnelle
Produits chimiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bronchiolite oblitérante : Questions médicales les plus fréquentes",
"headline": "Bronchiolite oblitérante : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bronchiolite oblitérante : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-04",
"dateModified": "2026-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bronchiolite oblitérante"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Bronchopneumopathies obstructives",
"url": "https://questionsmedicales.fr/mesh/D008173",
"about": {
"@type": "MedicalCondition",
"name": "Bronchopneumopathies obstructives",
"code": {
"@type": "MedicalCode",
"code": "D008173",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381.495"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pneumonie organisée",
"alternateName": "Organizing Pneumonia",
"url": "https://questionsmedicales.fr/mesh/D000092124",
"about": {
"@type": "MedicalCondition",
"name": "Pneumonie organisée",
"code": {
"@type": "MedicalCode",
"code": "D000092124",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381.495.146.135.140.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pneumonie organisée cryptogénique",
"alternateName": "Cryptogenic Organizing Pneumonia",
"url": "https://questionsmedicales.fr/mesh/D018549",
"about": {
"@type": "MedicalCondition",
"name": "Pneumonie organisée cryptogénique",
"code": {
"@type": "MedicalCode",
"code": "D018549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381.495.146.135.140.600.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Bronchiolite oblitérante",
"alternateName": "Bronchiolitis Obliterans",
"code": {
"@type": "MedicalCode",
"code": "D001989",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ralf Schubert",
"url": "https://questionsmedicales.fr/author/Ralf%20Schubert",
"affiliation": {
"@type": "Organization",
"name": "Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic Fibrosis, University Hospital Frankfurt, Goethe University, Frankfurt, Germany."
}
},
{
"@type": "Person",
"name": "Stefan Zielen",
"url": "https://questionsmedicales.fr/author/Stefan%20Zielen",
"affiliation": {
"@type": "Organization",
"name": "Division for Allergy, Pneumology and Cystic Fibrosis Department for Children and Adolescence Goethe University Frankfurt Germany."
}
},
{
"@type": "Person",
"name": "Yu-Cong Ma",
"url": "https://questionsmedicales.fr/author/Yu-Cong%20Ma",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, The First Hospital of Jilin University, Changchun, Jilin, PR China."
}
},
{
"@type": "Person",
"name": "Alejandro J Colom",
"url": "https://questionsmedicales.fr/author/Alejandro%20J%20Colom",
"affiliation": {
"@type": "Organization",
"name": "Centro Respiratorio, Hospital de Niños \"Dr. Ricardo Gutiérrez\", Buenos Aires, Argentina."
}
},
{
"@type": "Person",
"name": "Sevgi Pekcan",
"url": "https://questionsmedicales.fr/author/Sevgi%20Pekcan",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatric Pulmonology, Meram Medicine Faculty, Necmettin Erbakan University, Konya, Turkey."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Environmental and occupational bronchiolitis obliterans: new reality.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37598462",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ebiom.2023.104760"
}
},
{
"@type": "ScholarlyArticle",
"name": "Periostin in Bronchiolitis Obliterans Syndrome after Lung Transplant.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39408746",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms251910423"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between Polyunsaturated Fatty Acid Profile and Bronchial Inflammation in Bronchiolitis Obliterans.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37448886",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2023/3406399"
}
},
{
"@type": "ScholarlyArticle",
"name": "Successful treatment of postinfectious bronchiolitis obliterans with gamma globulin in a tertiary center: 10 years of experience.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37469295",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ppul.26577"
}
},
{
"@type": "ScholarlyArticle",
"name": "Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence.",
"datePublished": "2023-07-04",
"url": "https://questionsmedicales.fr/article/37402896",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00408-023-00632-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies pulmonaires",
"item": "https://questionsmedicales.fr/mesh/D008171"
},
{
"@type": "ListItem",
"position": 4,
"name": "Bronchopneumopathies obstructives",
"item": "https://questionsmedicales.fr/mesh/D008173"
},
{
"@type": "ListItem",
"position": 5,
"name": "Bronchiolite oblitérante",
"item": "https://questionsmedicales.fr/mesh/D001989"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bronchiolite oblitérante - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bronchiolite oblitérante",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bronchiolite oblitérante",
"description": "Comment diagnostique-t-on la bronchiolite oblitérante ?\nQuels tests sont utilisés pour évaluer la fonction pulmonaire ?\nLes imageries sont-elles utiles dans le diagnostic ?\nQuels symptômes cliniques sont observés ?\nLa biopsie pulmonaire est-elle toujours nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D001989#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bronchiolite oblitérante",
"description": "Quels sont les principaux symptômes de la bronchiolite oblitérante ?\nLes symptômes peuvent-ils varier selon les patients ?\nLa fièvre est-elle un symptôme courant ?\nLes symptômes s'aggravent-ils avec le temps ?\nPeut-on avoir des symptômes similaires à l'asthme ?",
"url": "https://questionsmedicales.fr/mesh/D001989#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bronchiolite oblitérante",
"description": "Comment prévenir la bronchiolite oblitérante ?\nLe tabagisme influence-t-il le risque ?\nLes vaccinations peuvent-elles aider ?\nY a-t-il des mesures à prendre après une greffe ?\nLes environnements pollués sont-ils un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D001989#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bronchiolite oblitérante",
"description": "Quels traitements sont disponibles pour la bronchiolite oblitérante ?\nLa transplantation pulmonaire est-elle une option ?\nLes antibiotiques sont-ils efficaces ?\nLes traitements peuvent-ils améliorer la qualité de vie ?\nY a-t-il des traitements expérimentaux disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D001989#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bronchiolite oblitérante",
"description": "Quelles sont les complications possibles de la bronchiolite oblitérante ?\nL'insuffisance respiratoire est-elle fréquente ?\nLes infections pulmonaires sont-elles courantes ?\nLa fibrose pulmonaire est-elle réversible ?\nLes complications peuvent-elles affecter la survie ?",
"url": "https://questionsmedicales.fr/mesh/D001989#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bronchiolite oblitérante",
"description": "Quels sont les principaux facteurs de risque ?\nLes antécédents médicaux influencent-ils le risque ?\nL'âge est-il un facteur de risque ?\nLes travailleurs exposés à des produits chimiques sont-ils à risque ?\nLes maladies respiratoires préexistantes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001989#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la bronchiolite oblitérante ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, les tests fonctionnels respiratoires et la biopsie pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la fonction pulmonaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la spirométrie et la mesure des volumes pulmonaires."
}
},
{
"@type": "Question",
"name": "Les imageries sont-elles utiles dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la tomodensitométrie (TDM) peut montrer des signes d'obstruction des bronchioles."
}
},
{
"@type": "Question",
"name": "Quels symptômes cliniques sont observés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une toux persistante, un essoufflement et une respiration sifflante."
}
},
{
"@type": "Question",
"name": "La biopsie pulmonaire est-elle toujours nécessaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est souvent réservée aux cas atypiques ou lorsque le diagnostic est incertain."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux symptômes de la bronchiolite oblitérante ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, dyspnée, fatigue et respiration sifflante."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier selon les patients ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la durée des symptômes peuvent varier d'un patient à l'autre."
}
},
{
"@type": "Question",
"name": "La fièvre est-elle un symptôme courant ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fièvre n'est pas typique, mais elle peut survenir en cas d'infection associée."
}
},
{
"@type": "Question",
"name": "Les symptômes s'aggravent-ils avec le temps ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'aggraver progressivement."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes similaires à l'asthme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la respiration sifflante et la toux peuvent ressembler à ceux de l'asthme."
}
},
{
"@type": "Question",
"name": "Comment prévenir la bronchiolite oblitérante ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des irritants pulmonaires et traiter les infections respiratoires rapidement."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de développer des maladies pulmonaires, y compris la bronchiolite oblitérante."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations contre les infections respiratoires peuvent réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures à prendre après une greffe ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier et des traitements immunosuppresseurs sont essentiels après une greffe."
}
},
{
"@type": "Question",
"name": "Les environnements pollués sont-ils un facteur de risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pollution de l'air peut contribuer à l'aggravation des maladies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la bronchiolite oblitérante ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les corticostéroïdes, les bronchodilatateurs et la réhabilitation pulmonaire."
}
},
{
"@type": "Question",
"name": "La transplantation pulmonaire est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la transplantation pulmonaire peut être envisagée dans les cas sévères et réfractaires."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ne sont pas efficaces contre la bronchiolite oblitérante, sauf en cas d'infection."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils améliorer la qualité de vie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement approprié peut améliorer la qualité de vie et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme les thérapies biologiques, sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la bronchiolite oblitérante ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire, les infections pulmonaires et la fibrose pulmonaire."
}
},
{
"@type": "Question",
"name": "L'insuffisance respiratoire est-elle fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'insuffisance respiratoire est une complication grave qui peut survenir."
}
},
{
"@type": "Question",
"name": "Les infections pulmonaires sont-elles courantes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent être plus susceptibles aux infections pulmonaires en raison de l'obstruction."
}
},
{
"@type": "Question",
"name": "La fibrose pulmonaire est-elle réversible ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la fibrose pulmonaire est généralement irréversible et peut aggraver la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la survie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications graves peuvent réduire l'espérance de vie des patients atteints."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des irritants, des infections virales et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies pulmonaires ou auto-immunes augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus susceptibles de développer des complications."
}
},
{
"@type": "Question",
"name": "Les travailleurs exposés à des produits chimiques sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition professionnelle à des produits chimiques peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les maladies respiratoires préexistantes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO peuvent prédisposer à la bronchiolite oblitérante."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/03/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic Fibrosis, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Publications dans "Bronchiolite oblitérante" :
3 publications dans cette catégorie
Affiliations :
Division for Allergy, Pneumology and Cystic Fibrosis Department for Children and Adolescence Goethe University Frankfurt Germany.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, The First Hospital of Jilin University, Changchun, Jilin, PR China.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Centro Respiratorio, Hospital de Niños "Dr. Ricardo Gutiérrez", Buenos Aires, Argentina.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatric Pulmonology, Meram Medicine Faculty, Necmettin Erbakan University, Konya, Turkey.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Brain Korea 21 PLUS Project for Medical Science, Severance Hospital, Institute of Allergy, Institute for Immunology and Immunological Diseases, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Experimental Transplantation and Immunology Branch, NIH, Bethesda, MD, USA.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC, USA.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
The First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
The First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
The First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Division for Allergy, Pneumology and Cystic Fibrosis Department for Children and Adolescence Goethe University Frankfurt Germany.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Division for Allergy, Pneumology and Cystic Fibrosis Department for Children and Adolescence Goethe University Frankfurt Germany.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Division for Allergy, Pneumology and Cystic Fibrosis Department for Children and Adolescence Goethe University Frankfurt Germany.
Publications dans "Bronchiolite oblitérante" :
2 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medicaland Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-shi, Niigata, 951-8510, Japan.
Publications dans "Bronchiolite oblitérante" :
Patients diagnosed with environmental/occupational bronchiolitis obliterans (BO) over the last 2 decades often present with an indolent evolution of respiratory symptoms without a history of high-leve...
The utility of measuring serum periostin levels for predicting the occurrence of bronchiolitis obliterans syndrome (BOS) after lung transplantation remains underexplored. We analyzed differentially ex...
Bronchiolitis obliterans (BO) is a chronic lung disease, which occurs after an insult to the lower airways, in particular after airway infections or after stem cell transplantation, and which results ...
Twenty-five patients with BO (age: 13; 7-39) and 26 healthy controls (age: 19; 7-31) participated in the study. Lung function (forced viral capacity (FVC), forced expiratory volume 1 (FEV1), residual ...
Patients presented with significantly lower FVC and FEV1 as well as higher RV and LCI measurements compared to the control group. Apart from a massive airway inflammation indicated by elevated numbers...
Lung function in BO is significantly impaired and associated with uncontrolled neutrophil-dominated airway inflammation. Furthermore, the imbalance in the AA/DHA ratio in favor of...
Bronchiolitis obliterans is characterized by partial or total occlusion of the bronchioles due to inflammation and fibrosis, and the most common form is postinfectious bronchiolitis obliterans (PIBO)....
The study included patients aged 0-18 with subtle immunological abnormalities who were followed up in our center for PIBO between 2010 and 2021. Clinical evaluation, body mass index (BMI), computerize...
Of the 11 patients included in the study, 90% were male, the mean age at diagnosis was 27.1 months (range: 5-68 months) and the mean current age was 81.4 months (range: 15-188 months). The number of h...
Corticosteroids are considered the best first-line treatment to control inflammation in PIBO. In our study group, PIBO patients showed favorable clinical and radiological responses to regular IVIG tre...
Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airflow limitation and an obstructive spirometry pattern without parenchymal opacities. The protein sign...
41 patients who had undergone LTX were enrolled. Of these, 27 developed BOS and 14 (control group) were considered stable at the time of serum sampling. Of BOS patients, serum samples were analysed at...
Serum concentrations of COL4A5 were higher in pre-BOS than in stable patients (40.5 ± 13.9 and 24.8 ± 11.4, respectively, p = 0.048). This protein is not influenced by comorbidities, such as acute rej...
Serum concentrations of COL4A5 can be considered a good prognostic marker due to their association with survival and correlation with functional parameters....
Bronchiolitis obliterans syndrome (BOS) is the lung manifestation of chronic graft-versus-host disease after hematopoietic stem cell transplantation (HSCT). We assessed whether inhaled tiotropium add-...
Post-HSCT patients diagnosed as BOS in Seoul St. Mary's Hospital were reviewed retrospectively. Patients defined as BOS and treated with budesonide/formoterol/tiotropium combination therapy after bude...
Total of 86 patients were evaluated. After tiotropium add-on, the absolute FEV1 increased significantly from 1.47 ± 0.49 to 1.53 ± 0.57 L (p = 0.023) and the % predicted FEV1 from 45.0 ± 12.8 to 46.8 ...
Inhaled tiotropium add-on to combination budesonide/formoterol significantly improved lung function, but not respiratory symptoms, in patients with post-HSCT BOS....
The percentage of low attenuation area (%LAA) on computed tomography (CT) is useful for evaluating lung emphysema, and higher %LAA was observed in patients with chronic lung allograft dysfunction (CLA...
We conducted a single-center retrospective study of 75 recipients who underwent bilateral LT; the recipients were divided into a CLAD group (n = 30) and a non-CLAD group (n = 45). The %LAA was calcula...
The %LAA was significantly higher in the CLAD group than in the non-CLAD group from 2 years before to 2 years after the diagnosis of CLAD (P < .05). In particular, patients with bronchiolitis oblitera...
The %LAA on CT was associated with the development of CLAD and appears to have the potential to predict CLAD, especially BOS, after bilateral LT....
Postinfectious bronchiolitis obliterans (PiBO) is a rare and severe form of chronic obstructive lung disease caused by an infectious injury to the lower respiratory tract. The most commonly recognized...
[This retracts the article DOI: 10.1155/2022/9371406.]....
BACKGROUND The association between forced expiratory volume in 1 second (FEV1) trajectory and mortality in bronchiolitis obliterans syndrome (BOS) is not well defined. Using long-term data from a prio...